Showing results (251-260 of 274) with videos related to
Sort By:
Pageof 28
Heart (British Cardiac Society)|September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeN M Hawkins, D Wang, J J V McMurray, et al.Circulation|February 24, 2001
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failureL Gullestad, H Aass, J G Fjeld, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 8, 2001
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]L Gullestad, H Aass, A K Andreassen, et al.The American Journal of Cardiology|May 1, 1983
Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarctionJ Herlitz, D Elmfeldt, A Hjalmarson, et al.American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.Lancet (London, England)|October 17, 1981
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trialA Hjalmarson, D Elmfeldt, J Herlitz, et al.Clinical Pharmacology and Therapeutics|November 7, 2013
An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudyJ A Batty, A S Hall, H L White, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cellsT Holm, J K Damås, K Holven, et al.Archives of Internal Medicine|October 14, 1996
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival StudyT R Pedersen, K Berg, T J Cook, et al.The American Journal of Cardiology|August 3, 2000
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol loweringT R Pedersen, L Wilhelmsen, O Faergeman, et al.Pageof 28